Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.
Genetic screen for monitoring hepatitis C virus NS3 serine protease activity.
Reduced fitness of HIV-1 resistant to CXCR4 antagonists.
Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Anti-HIV activity of a novel aminoglycoside-arginine conjugate.
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
RNA interference of HIV replication.